Clinical Trial Update: Safety and Immune Response to Adjuvanted A(H1N1)v Influenza Vaccine in HIV-1 Infected and Immunosuppressed Adult Patients [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating safety and immune response to an adjuvanted A(H1N1) influenza vaccine in HIV-infected and immunosuppressed adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• HIV Infection

Drugs mentioned

• Adjuvanted A(H1N1) influenza vaccine

Snippet

Sponsor: Goethe University | Conditions: HIV-1 Infection, Cancer | Phase 4 | Status: UNKNOWN